FINWIRES · TerminalLIVE
FINWIRES

Axon Enterprise to Raise 2026 Sales Guidance Supported by AI, New Products, RBC Says

By

Axon Enterprise (AXON) could beat Q1 estimates and raise the lower end of its fiscal 2026 revenue guidance as new products, wider use of its platform, AI add-ons, and faster drone deployments support growth, RBC Capital Markets said in a note Tuesday.

Axon's connected system should become stronger through fiscal 2026 as ABW Mini launches and drone-as-first-responder deployments send more real-time data into its Fusus and intelligence platforms. Its AI Era Plan conversions are expected to grow faster, helped by bundled products, customer upgrades, international expansion, and more federal and enterprise demand, RBC said.

Bookings may be seasonally softer in Q1, but growth should pick up later in fiscal 2026 as deal sizes rise and new products gain more traction, while international growth will slow down in 2026 because of long European sales cycles, but stronger gains are expected in 2027 and 2028 as cloud deployments expand and AI tools drive more platform use, according to the note.

The investment firm said Axon's mix of hardware, software, and data gives it a stronger position against lower-cost software rivals and supports wider customer adoption.

RBC maintained its outperform rating and $735 price target on the stock.

Price: $373.46, Change: $-20.29, Percent Change: -5.15%

Related Articles

Wire

IAC Q1 Loss Narrows, Revenue Falls; Shares Drop After Hours

IAC (IAC) reported a Q1 loss late Monday of $0.94 per diluted share, narrowing from the loss of $2.64 a year earlier.Analysts polled by FactSet expected a loss of $0.37.Revenue in the three months ended March 31 fell to $422.9 million from $481.7 million a year earlier.Analysts surveyed by FactSet expected $520.3 million.IAC shares fell 8.6% in after-hours trading.

$IAC
Wire

Vornado Realty Trust Q1 Non-GAAP FFO, Revenue Fall; Shares Drop After Hours

Vornado Realty Trust (VNO) reported Q1 non-GAAP funds from operations late Monday of $0.52 per diluted share, down from $0.63 a year earlier.Analysts polled by FactSet expected $0.51.Revenue in the three months ended March 31 fell to $459.1 million from $461.6 million a year earlier.Analysts surveyed by FactSet expected $431.7 million.Vornado shares fell 3% in after-hours trading.

$VNO
Wire

GeneDx Q1 Swings to Adjusted Loss, Revenue Rises; 2026 Revenue Guidance Lowered; Shares Fall

GeneDx (WGS) reported Monday Q1 adjusted loss of $0.28 per diluted share, swinging from an adjusted earnings of $0.31 a year earlier.Analysts polled by FactSet expected loss of $0.02.Revenue for the quarter ended March 31 was $102.3 million, up from $87.1 million a year earlier.Analysts surveyed by FactSet expected $112.5 million.For Q2, the company expects revenue of $110 million to $112 million. Analysts expect $130.3 million.The company now expects 2026 revenue of $475 million to $490 million, down from $540 million to $555 million expected earlier. Analysts expect $550.0 million.Shares of the company were down over 45% during after-hours activity.

$WGS